First Time Loading...

Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 15.05 AUD -1.25% Market Closed
Updated: May 7, 2024

Telix Pharmaceuticals Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Telix Pharmaceuticals Ltd
Operating Income Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
PYC

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Telix Pharmaceuticals Ltd
ASX:TLX
Operating Income
AU$17.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immutep Ltd
ASX:IMM
Operating Income
-AU$46.9m
CAGR 3-Years
-29%
CAGR 5-Years
-24%
CAGR 10-Years
-13%
Mesoblast Ltd
ASX:MSB
Operating Income
-$55.3m
CAGR 3-Years
21%
CAGR 5-Years
9%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Operating Income
$3.7B
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
9%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Operating Income
AU$50.8m
CAGR 3-Years
36%
CAGR 5-Years
27%
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Operating Income
-AU$21.2m
CAGR 3-Years
-28%
CAGR 5-Years
-22%
CAGR 10-Years
-17%

See Also

What is Telix Pharmaceuticals Ltd's Operating Income?
Operating Income
17.6m AUD

Based on the financial report for Dec 31, 2023, Telix Pharmaceuticals Ltd's Operating Income amounts to 17.6m AUD.